Patient Leaflet Updated 09-Feb-2023 | Glenmark Pharmaceuticals Europe Ltd
Nebivolol 1.25 mg Tablets
Nebivolol 1.25 mg Tablets
1. What Nebivolol Tablets are and what they are used for
2. What you need to know before you take Nebivolol Tablets
3. How to take Nebivolol Tablets
4. Possible side effects
5. How to store Nebivolol Tablets
6. Contents of the pack and other information
Nebivolol Tablets contains nebivolol, a cardiovascular drug belonging to the group of selective beta-blocking agents (i.e. with a selective action on the cardiovascular system). It prevents increased heart rate, controls heart pumping strength. It also exerts a dilating action on blood vessels, which contributes as well to lower blood pressure.
It is used to treat raised blood pressure (hypertension).
Nebivolol Tablets is also used to treat mild and moderate chronic heart failure in patients aged 70 years or over, in addition to other therapies.
Talk to your doctor or pharmacist before taking Nebivolol Tablets. Inform your doctor if you have or develop one of the following problems:
Nebivolol Tablets before being anaesthetised.
If you have serious kidney problems do not take Nebivolol Tablets for heart failure and tell your doctor.
You will be regularly monitored at the beginning of your treatment for chronic heart failure by an experienced physician (see section 3).
This treatment should not be stopped abruptly unless clearly indicated and evaluated by your doctor (see section 3).
Because of the lack of data on the use of the product in children and adolescents, Nebivolol Tablets are not recommended for use in them .
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Always tell your doctor if you are using or receiving any of the following medicines in addition to Nebivolol Tablets:
All these drugs as well as nebivolol may influence the blood pressure and/or heart function:
Please refer to section 3.
Pregnancy
Nebivolol Tablets should not be taken during pregnancy unless clearly necessary.
Breast-feeding
It is not recommended for use while breast-feeding.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
This medicine may cause dizziness or fatigue. If affected, do not drive or operate machinery.
This product contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per tablet that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Nebivolol Tablets may be taken before, during or after the meal, but, alternatively, you can take this medicine independently of meals. The tablet is best taken with some water.
Your treatment will be started and closely supervised by an experienced physician.
Do not use in children or adolescents.
If you accidentally take an overdose of this medicine, tell your doctor or pharmacist immediately. The most frequent symptoms and signs of a Nebivolol overdose are very slow heart beat (bradycardia), low blood pressure with possible fainting (hypotension), breathlessness such as in asthma (bronchospasm), and acute heart failure.
You can take activated charcoal (which is available at your pharmacy) while you wait for the arrival of the doctor.
If you forget a dose of Nebivolol tablet, but remember a little later on that you should have taken it, take that day’s dose as usual.. However, if a long delay has occurred (e.g. several hours), so that the next due dose is near, skip the forgotten dose and take the next, scheduled, normal dose at the usual time. Do not take a double dose. Repeated skipping, however, should be avoided.
You should always consult with your doctor before stopping Nebivolol Tablets treatment , whether you are taking it for high blood pressure or chronic heart failure.
You should not stop Nebivolol Tablets treatment abruptly as this can temporarily make your heart failure worse.
If it is necessary to stop Nebivolol Tablets treatment for chronic heart failure, the daily dose should be decreased gradually, by halving the dose at weekly intervals. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop taking Nebivolol and talk to your doctor immediately if you have any of the following side effects:
When Nebivolol Tablets is used for the treatment of raised blood pressure, the possible side effects are:
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Very rare side effects (may affect up to 1 in 10,000 people):
The following side effects have been reported only in some isolated cases during treatment with this medicine:
In a clinical study for chronic heart failure, the following side effects were seen:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people)
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the blister after <EXP>. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
If the medicine becomes discoloured or shows any other signs of deterioration, you should seek the advice of your pharmacist who will tell you what to do.
The active substance is nebivolol.
Each tablet contains 1.25 mg of nebivolol equivalent to 1.363 mg of nebivolol hydrochloride.
The other ingredients are: lactose monohydrate; maize starch; croscarmellose sodium; hypromellose; microcrystalline cellulose; silica colloidal anhydrous; magnesium stearate.
Circular, white, biconvex uncoated tablets, approximately 4.95 mm in size, debossed with “G” on one side and “7” on the other side.
Nebivolol 1.25mg Tablets are available in PVC/PVDC/aluminium blisters and aluminium/ aluminium blisters of 14, 28, 30, 50, 90, 98, 100 tablets
*Not all pack sizes may be marketed.
This leaflet was last revised in 04/2022.
Building 2, Croxley Park, Watford, WD18 8YA
+44 (0)1923 251137
www.glenmarkpharma.com
+44 (0)1923 202 950
0800 458 0383
+44 (0)1923 202 950